Legal & General Group’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.3M Buy
256,749
+16,106
+7% +$128K ﹤0.01% 1860
2025
Q4
$1.45M Sell
240,643
-4,328
-2% -$25.8K ﹤0.01% 2093
2025
Q3
$1.4M Sell
244,971
-3,755
-2% -$19.2K ﹤0.01% 2129
2025
Q2
$1.25M Buy
248,726
+13,876
+6% +$74.4K ﹤0.01% 2169
2025
Q1
$1.52M Buy
234,850
+2,867
+1% +$25.5K ﹤0.01% 2022
2024
Q4
$1.7M Sell
231,983
-13,821
-6% -$109K ﹤0.01% 2044
2024
Q3
$1.84M Buy
245,804
+2,408
+1% +$20.9K ﹤0.01% 2014
2024
Q2
$2.17M Sell
243,396
-7,893
-3% -$75.7K ﹤0.01% 1916
2024
Q1
$2.55M Buy
251,289
+6,722
+3% +$68.5K ﹤0.01% 1827
2023
Q4
$2.46M Buy
244,567
+902
+0.4% +$8.24K ﹤0.01% 1850
2023
Q3
$2.28M Buy
243,665
+15,682
+7% +$224K ﹤0.01% 1839
2023
Q2
$5.59M Buy
227,983
+5,781
+3% +$145K ﹤0.01% 1398
2023
Q1
$5.17M Sell
222,202
-137
-0.1% -$3.5K ﹤0.01% 1397
2022
Q4
$5.63M Buy
222,339
+3,901
+2% +$95.6K ﹤0.01% 1340
2022
Q3
$4.21M Buy
218,438
+4,181
+2% +$106K ﹤0.01% 1440
2022
Q2
$5.46M Buy
214,257
+158,982
+288% +$3.71M ﹤0.01% 1367
2022
Q1
$1.42M Buy
55,275
+315
+0.6% +$9.34K ﹤0.01% 2112
2021
Q4
$2.3M Buy
54,960
+1,026
+2% +$40.2K ﹤0.01% 1975
2021
Q3
$2.35M Buy
53,934
+9,254
+21% +$401K ﹤0.01% 1949
2021
Q2
$2.11M Buy
44,680
+16,371
+58% +$744K ﹤0.01% 1946
2021
Q1
$1.45M Sell
28,309
-7,851
-22% -$423K ﹤0.01% 2100
2020
Q4
$967K Buy
36,160
+8,875
+33% +$288K ﹤0.01% 2124
2020
Q3
$937K Sell
27,285
-1,160
-4% -$49.9K ﹤0.01% 2046
2020
Q2
$1.16M Buy
28,445
+27,316
+2,419% +$917K ﹤0.01% 1930
2020
Q1
$39K Sell
1,129
-353
-24% -$9.49K ﹤0.01% 2682
2019
Q4
$19K Buy
+1,482
New +$19.9K ﹤0.01% 3205

Other funds holding VIR